We aim to establish the Tonomachi-Haneda area as a key cluster supporting regenerative medicine in Japan, leveraging special zone systems such as the International Strategic Zone and the National Strategic Special Zone.

The development and commercialization of regenerative medical products involve many processes distinct from traditional pharmaceuticals, and various challenges have emerged. To address these challenges, it is essential not only to develop globally competitive seeds but also to build a robust value chain that supports their social implementation. Through various national initiatives, and with the cooperation of companies, including members of the Regenerative medicine＆cell therapy Industrialization network of Kanagawa (RINK), we have worked to establish a stable supply system for raw materials, a manufacturing and quality assessment infrastructure, and a value chain to facilitate the social implementation of regenerative and cellular medical products. Additionally, we have collaborated with organizations such as the Central Institute for Experimental Medicine and Life Science (CIEM), the National Institute of Health Sciences (NIH), RIKEN, and the Kanagawa Institute of Industrial Science and Technology (KISTEC) to clarify the quality characteristics and mode of action of raw materials and products, thereby establishing a system that links to advanced medical care and pharmaceutical approvals.

Furthermore, to ensure that patients receive safe and reliable regenerative medicine as quickly as possible, we recognize the importance of not only public insurance systems but also new, trustworthy medical frameworks. We have made efforts to build a system for reverse translational researches, collecting high-quality medical data and information obtained through the manufacturing and processing of regenerative medical products in collaboration with relevant institutions. Through this initiative, we aim to create a system that enables citizens to make informed choices about cutting-edge medical treatments based on solid evidence of their efficacy and safety.

Additionally, we seek to utilize the geographical advantage of our location near Haneda Airport to support various initiatives, including networking with domestic and international organizations and developing inbound medical services for foreign visitors. Our goal is to enable the seeds cultivated at this cluster to expand beyond Japan and contribute to the global advancement of regenerative medicine.

This cluster has already attracted a diverse range of stakeholders who share the vision of developing the Tonomachi-Haneda area into a center for regenerative medicine.

Let us work together to shape the future of regenerative medicine!